DarioHealth Appoints John R. Palumbo to Board: Strategic Move for Accelerated Commercial Growth
DarioHealth Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors
Strategic Board Addition Signals Next Phase of Commercial Growth and Market Expansion
NEW YORK, April 13, 2026 — DarioHealth Corp. (NASDAQ: DRIO), a leader in global digital health, has announced the appointment of industry veteran John R. Palumbo to its Board of Directors. This key addition is expected to play a pivotal role in supporting Dario’s accelerated commercial scaling and unlocking the company’s full strategic value.
Key Highlights for Investors
-
Strategic Appointment to Support Commercial Scaling: Mr. Palumbo brings over 40 years of healthcare operating experience, spanning early-stage ventures to Fortune 100 enterprises. His deep relationships with health systems, payers, and senior healthcare executives are anticipated to facilitate new commercial partnerships and drive Dario’s go-to-market strategy.
-
Proven Track Record in Healthcare Leadership: Mr. Palumbo has held senior leadership roles at top companies such as AmerisourceBergen Corporation (now Cencora, Inc.), where he led the provider business unit and expanded it into a multibillion-dollar platform. He was also COO of Allscripts Healthcare Solutions (now Veradigm, Inc.) and held leadership positions at Shared Medical Systems Corporation (Siemens AG), guiding organizations through IPOs and large-scale operational transformations.
-
Deep Industry Connections: Palumbo’s relationships with decision-makers across payer, provider, and health services landscapes are expected to be invaluable as Dario seeks to build and scale its market presence. His expertise aligns with Dario’s shift toward a capital-efficient, partner-led commercial model.
-
Active Role in Digital Health Innovation: Palumbo currently serves on several other health-related boards, including PM Pediatrics Management Group, Lucid Diagnostics, ivWatch, and Qless, and chairs the advisory board of Brado Cuneo Nollau, an AI-driven engagement platform for health systems.
-
Board and Management Endorse Support for Growth Trajectory: Dario’s CEO, Erez Raphael, underscored the strategic value of Palumbo’s appointment as the company transitions from proving its distribution model to scaling it efficiently through channel partnerships. Palumbo’s history of guiding organizations through consequential strategic transactions and transformations is expected to directly support Dario’s growth objectives.
-
Inflection Point for Dario: Palumbo commented on Dario’s differentiated, integrated solution and strong engagement metrics, emphasizing the opportunity to scale value through optimal commercial channels and strategic partnerships.
Potentially Price-Sensitive Information
-
Accelerated Commercial Partnerships: The board addition is explicitly intended to speed up the formation of new commercial partnerships, which could significantly impact Dario’s revenue streams and market share.
-
Positioning for Strategic Value Realization: The move is designed to help Dario capture the full strategic opportunity of its platform, which could lead to increased investor confidence and share price appreciation if successful.
-
Enhanced Market Reach and Capital Efficiency: Palumbo’s experience is highly relevant to Dario’s evolution toward a more capital-efficient, partner-led growth strategy—a factor that could improve operational leverage and financial performance.
-
Board Alignment with Next Phase of Growth: The realignment of the board composition signals management’s focus on scaling and commercial execution, which is often viewed positively by institutional investors.
About DarioHealth Corp.
DarioHealth Corp. is a leading digital health company focused on empowering people with chronic conditions to manage their health through a user-centric, digital therapeutics platform. The company’s solutions deliver personalized, dynamic interventions driven by data analytics and one-on-one coaching for conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Dario’s platform offers continuous, customized care, aiming to improve user satisfaction, retention, and health outcomes by enabling sustainable lifestyle changes. The company provides its solutions globally to health plans, self-insured employers, care providers, and consumers.
For more information, visit dariohealth.com.
Forward-Looking Statements
This news release contains forward-looking statements, including expectations that Mr. Palumbo’s experience will support Dario’s growth trajectory and accelerate commercial partnerships. Actual results could differ due to various risks, including regulatory approvals, market acceptance, competition, technological challenges, and the adequacy of capital resources. Readers should review the company’s filings with the SEC for additional risk factors.
Contact Information
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. The information provided herein is based on publicly available sources and company statements as of the date of publication, and no warranty is given as to its accuracy or completeness.
View DarioHealth Corp. Historical chart here
